Ann: Quarterly Commentary, page-6

Well, I figure out that being a listed shell company is better than being a cash cow for Proxima and Dr New, and anyone reading the latest Annual Report would agree.
Since the tests on rats shown that the licence agreement wasn't worth a toss - with a big "IF" on any prospect of commercialization more than a decade away -the odds look better to me now, to give one example: empty shell, with a fraction of the cash of BNE and "no prospects", MRY......hmm
I 'm also figuring out that, just as last year there was an ominous sell off while waiting for the results of the study on BNOO6, the recent spike in volume while waiting is a positive sign, someone 's bought a big parcel.
From your disclosure I can see that you've sold, if I was to sell now I' d take a loss of 35k +. I don' t need to sell so I 'll hold and see.
Wishing you to make ten times what you lost on this one with your other investments.